Discussion paper about a new treatment or prevention technique for diabetes mellitus

A NEW TREATMENT FOR DIABETES MELLITUS. A NEW TREATMENT FOR DIABETES MELLITUS. The world is grappling with shocking statistics of soaring cases of diabetes mellitus that new treatment has become a priority for medical practitioners. Diabetes mellitus is a condition resulting from failure of the pancreas to produce hardly any insulin. This increases the level of glucose in the blood therefore leading to chronic hyperglycemia. Sitagliptin is a new medicine used by people with diabetes 2 whose blood sugar cannot be controlled with certain medicine. It controls glucose to reduce complications that result from diabetes mellitus.
(Sharp M. & Dohme, 2009) “ Ground Breaking Research Delivers New Treatment for Type 2 Diabetes” wrote that sitagliptin was a break-through in treatment of people with diabetes mellitus (Sharp M. & Dohme, 2009). Oral medication is used to lower blood glucose for people with type 2 diabetes who are unable to lower their blood glucose level effectively. The body is allowed to produce its own insulin so the liver cannot produce too much glucose. Some studies indicate sitagliptin leads to pancreatitis. Should we then advise patients to use sitagliptin?
Prevention of diabetes mellitus has three dimensions: blood pressure, glycemia and lipid levels that must be addressed (Fiona H., 2008). If faced with complicated clinical situations, Patients are advised to turn to professionals who advise on best care as far as nutrition and medication is concerned. It is advised that we should embrace low glycemic diets and healthy cuisine and lifestyle as preventive technique. To Fiona H. (2008), sitagliptin is not a priority.
Melanie V., Cheryl S., Kathryn P., & Peter G. (2003) conducted eating and pumping research. They administered research to establish how nutritional information in an insulin pump clinic affects knowledge. Melanie et al., (2003) found that nutritional information increased with increase in number of people attending insulin clinic. They lived a healthy lifestyle. Inevitably, sharing of information among Community of people with diabetes mellitus plays an astounding role in its treatment. As a fact, diabetes community ensures that patients benefit from interactive forum therefore dispelling myths surrounding the use of sitagliptin.
It is a common misconception for people with diabetes to say.”…diabetes is in our family…” Fiona H. (2008) refutes this myth. A good number of people are genetically susceptible to type-2 diabetes. Sitagliptin could be handy. A personal lifestyle and diet rich in reined carbohydrates, trans-fatty acids, caffeinated beverages, smoking and high stress are risky factors. With this lifestyle, one cannot use Sitagliptin. It is advised that patients should live normal life while taking instruction from dieticians and physicians.
New ideas present new challenges and Sitagliptin as a treatment of diabetes mellitus is no exception. A few people have developed Pancreatitis after starting Sitagliptin. It has not been proven yet if for sure Sitagliptin caused the pancreatitis. Williams-Herman D., Round E., Swern AS., Musser B., Davies MJ., Stein PP et al., (2008) conducted a clinical study using data on 6, 139 patients who had type two diabetes treatments with Sitagliptin to update its safety and tolerability. Debora W. et. al, (2008) found that treatment with Sitagliptin was well tolerated than those observed with other treatments. This breakthrough in treatment of diabetes is a great relieve for many who thought it a death penalty.
Williams-Herman D., Round E., Swern AS., Musser B., Davies MJ., Stein PP., (2008): Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis. BMC Endocr Disord, 8: 14.
Melanie V., Cheryl S., Kathryn P., & Peter G.(2003). Eating and Pumping: Evaluating the Nutrition Service of the insulin pump clinic at the Royal Melbourne Hospital: The Journal of the Dietitian Association of Australia. 60, 122–5.
Fiona H. (2008). Australia Diabetes Society/Australian Diabetes Educators AssociationMeetings. 6-7 (website)
Merck S. & Dohme.(2009.) Ground-Breaking Research Delivers New Treatment for Type 2
Filed under:
Media Release, ANU College of Medicine Biology and Environment, Health, Science, Staff
Diabetes. 54-68